Abstract
The transcription factor forkhead box D3 (FOXD3), widely studied as a transcriptional repressor in embryogenesis, participates in the carcinogenesis of many cancers. However, the expression pattern and role of FOXD3 in non-small cell lung cancer (NSCLC) have not been well characterized. We report that FOXD3 is significantly downregulated in NSCLC cell lines and clinical tissues. FOXD3 overexpression significantly inhibits cell growth and results in G1 cell cycle arrest in NSCLC A549 and H1299 cells. In a xenograft tumor model, FOXD3 overexpression inhibits tumor growth and angiogenesis. Remarkably, expression of vascular endothelial growth factor (VEGF) was reduced in FOXD3 overexpression models both in vitro and in vivo. These findings suggest that FOXD3 plays a potential tumor suppressor role in NSCLC progression and represents a promising clinical prognostic marker and therapeutic target for this disease.
References
Sep 20, 1996·The Journal of Biological Chemistry·J SuttonR Hromas
Oct 17, 2002·Genes & Development·Lynn A HannaPatricia A Labosky
Jul 26, 2005·Developmental Biology·Dennie M TompersPatricia A Labosky
Jun 24, 2006·The Biochemical Journal·Patrick J E C WijchersMarten P Smidt
Oct 19, 2007·Nature Reviews. Cancer·Stephen S Myatt, Eric W-F Lam
Oct 25, 2008·Molecular Cancer·Paul P AnglimIte A Laird-Offringa
Dec 11, 2008·Pigment Cell & Melanoma Research·Aaron J Thomas, Carol A Erickson
Mar 9, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Xianhuo WangLijuan Chen
Apr 12, 2011·Molecular Cancer Research : MCR·Pragati Katiyar, Andrew E Aplin
Nov 22, 2011·Cancer Letters·Wei ZhouChun-You Wang
Oct 2, 2012·Cancer Letters·Masuko KatohMasaru Katoh
Oct 13, 2012·Gastroenterology·Alfred S L ChengFrancis K L Chan
Nov 10, 2012·Irish Journal of Medical Science·B S Al-AlaoV K Young
May 17, 2013·The Journal of Clinical Investigation·Ye ChenMichael Andreeff
Mar 19, 2014·Biochemical and Biophysical Research Communications·Tian-Li ChuJie Ge
Jul 26, 2014·Molecular Cancer Research : MCR·Michele B WeissAndrew E Aplin
Dec 3, 2014·Biochemical and Biophysical Research Communications·Zhan-Guo ZhangBi-Xiang Zhang
Jan 16, 2015·World Journal of Surgical Oncology·Ji-Chang HanYi-Jie Zhang
Citations
Feb 6, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xiao WangYandong Li
Mar 11, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zhai ErtaoWu Hui
Feb 1, 2019·Stem Cells·Wei XuJianru Xiao
Dec 1, 2019·Carcinogenesis·Ming XuXiaotong Hu
Dec 8, 2016·Oncotarget·Kun LiLei Li
Apr 22, 2017·Oncotarget·Huabin YinDianwen Song
Feb 13, 2018·Oncology Letters·Wenhua JiangXiaodong Li
Mar 13, 2019·Cancer Cell International·Gui-Fang LuoYan Li
Mar 18, 2016·International Journal of Oncology·Youchao JiaYan Fu
Oct 27, 2018·International Journal of Molecular Sciences·Duc-Hiep BachSang Kook Lee
Jan 16, 2020·Nature Communications·Fang TaiJian Shi
Aug 6, 2019·Endocrine·Heewa ShakibMehdi Hedayati
Apr 2, 2020·Frontiers in Cell and Developmental Biology·Xiao-Ling MaYi Lin
May 28, 2020·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Xiaoxing XieXiaoying Cui
Aug 31, 2017·Molecular Cancer Research : MCR·Shubhashish SarkarPomila Singh
Dec 22, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Roberto CostaLuigi Leanza
Feb 24, 2019·Trends in Molecular Medicine·Stephanie DoberschGuillermo Barreto